Description
Buy Zepbound 2.5mg/0.5mL-Zepbound Weight Loss Injection Online
Zepbound 2.5mg/0.5mL is a prescription medication used to support weight loss in adults, particularly those with obesity or overweight conditions. It contains tirzepatide, a dual GLP-1 and GIP receptor agonist, which helps regulate blood sugar levels and reduces appetite. Zepbound is designed to zepbound 2.5 mg/0.5 ml pen promote fat loss, making it an effective treatment for those struggling to lose weight, especially in combination zepbound medication with a healthy diet and regular exercise.
The 2.5mg/0.5mL dose is typically the starting dose, allowing the body to gradually zepbound class adjust to the medication before increasing to higher doses if needed. Zepbound works by zepbound 2.5 mg weight loss mimicking natural hormones that influence hunger and insulin production, helping zepbound users feel fuller for longer periods and reducing calorie intake.
Administered once a week via a subcutaneous injection in areas like the abdomen, thigh, or upper arm, Zepbound is easy to use and provides significant convenience. While side effects may include zepbound 5 mg weight loss nausea, vomiting, or diarrhea, these symptoms often improve with time.
Zepbound 2.5mg/0.5mL is a prescription-only medication, and it’s essential to consult a healthcare provider before beginning treatment to ensure safety and maximize weight loss benefits.
Product Specification for Zepbound 2.5mg/0.5mL:
1. Product Description:
- Zepbound is a medication containing tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.
- This specific product provides a 2.5mg dose of tirzepatide in a 0.5mL solution for subcutaneous injection.
- It is designed to be used in conjunction with a reduced-calorie diet and increased physical activity for chronic weight management in adults.
2. Indications:
- Indicated for chronic weight management in adults with:
- A body mass index (BMI) of 30 kg/m² or greater (obesity).
- A BMI of 27 kg/m² or greater (overweight) with at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease).
- Also indicated for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
3. Dosage and Administration:
- The recommended starting dosage is 2.5 mg injected subcutaneously once weekly.
- This 2.5mg dosage is for initiation of treatment, and not for maintenance.
- Administer once weekly at any time of day, with or without meals.
- Injection sites: abdomen, thigh, or upper arm (rotate injection sites).
4. Dosage Form and Strength:
- Solution for subcutaneous injection.
- 2.5 mg/0.5 mL in single-dose pens or single-dose vials.
5. Key Features:
- GIP and GLP-1 receptor agonist.
- Once-weekly administration.
- Aids in weight loss and weight maintenance.
6. Storage:
- Store in the refrigerator between 36°F to 46°F (2°C to 8°C).
- Do not freeze.
- Store single-dose pens in the original carton to protect from light.
- If needed, single dose pens can be stored at room temperature up to 86⁰F (30⁰C) for up to 21 days.
7. Important Safety Information:
- Consult the full prescribing information for contraindications, warnings, and precautions.
- Potential side effects include nausea, diarrhea, vomiting, and constipation.
- Not recommended for patients with severe gastrointestinal disease.
- May cause fetal harm.
- Always consult with a healthcare professional before starting any weight loss medication.
8. Legal Status:
- Prescription medication.
Disclaimer: This product specification is for informational purposes only and should not be considered medical advice. Always consult with a healthcare professional before starting any new medication.
Reviews
There are no reviews yet.